PSA Level Chart PSA Velocity 3 Other Tests Comments More PSA levels between 4.0 and 10.0 ng/mL might suggest the possibility of prostate cancer (in about 25 percent of cases) or BPH. Prostate-specific antigen (PSA) is a protein produced by the glandular tissue of the prostate (a ...
High Levels of the PSA (Prostate Specific Antigen) In Patients with Benign Prostatic Hyperplasia and Prostate CancerRishu BansaliMedPub
Prostate cancer PSA: Prostate-specific antigen ROI: Region of interest RP: Radical prostatectomy SBS: Single base substitution (signature) SNV: Single nucleotide variant SV: Structural variant SV: Seminal vesicle TD: Tandem duplication VOI: Volume of interest WGS: Whole genome sequencin...
High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience. the magnetic resonance (MR) and MR spectroscopic imaging features of high-grade prostatic intraepithelial neoplasia (HGPIN) in patients with prostate cancer. ... ...
PRESTO: a phase III, open-label study of androgen annihilation in patients (pts) with high-risk biochemically relapsed prostate cancer (AFT-19) (Abstract LBA 63) Rahul Aggarwal, MD Intensification of androgen-deprivation therapy (ADT) plus apalutamide (Erleada) displayed promising efficacy in pa...
Portland, OR-Weekly preoperative chemotherapy with docetaxel (Taxotere)and mitoxantrone (Novantrone) reduced PSA levels and was associated witha high rate of negative surgical margins in a small preliminary clinicaltrial involving high-risk localized prostate cancer patients....
(2012) Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis. ... C Li,L Xu,X Lin,... - 《Medicine》 被引量: 0发表: 2021年 Statin use and fatal prostate cancer BACKGROUND:Statins are some of the ...
(ADT) in a single institution.Between March 2003 and December 2011, 155 consecutive high-risk prostate cancer patients (a) presenting with pre-treatment PSA level a parts per thousand yen20 ng/mL, (b) treated with definitive EBRT, and (c) with a minimum follow-up of 24 months were ...
PSA and PSA velocity (PSAV, rate of PSA change over time) are biomarkers for diagnosis and prognosis of prostate cancer. Men who are at high risk for prostate cancer also have associated comorbidities for which they are taking NSAIDs and statins for long periods; therefore, it is important ...
A combination of HDR brachytherapy boost and EBRT provides a high BED with high rates of disease control and excellent disease specific survival for patients with Gleason 8 through 10 prostate cancer even with iPSA up to 40ng/ml. Hormonal therapy did not improve outcomes in this cohort of patie...